This is a routine proxy reminder, no material new information. The equity plan amendment could be dilutive if it adds significant share reserves, but details are not in this filing. Monitor the definitive proxy statement for share counts. The meeting is six weeks away; no immediate trading catalyst.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 30 $67.50entry
- T+1 · 5mo ago −3.07%α −2.93% · $65.43
- T+5 · 4mo ago −7.69%α −8.29% · $62.31
- T+20 · 4mo ago −20.58%α −19.55% · $53.61
- T+60 · 8w ago −24.79%α −28.35% · $50.77
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
AnaptysBio filed definitive additional proxy soliciting materials (DEFA14A) for its August 11, 2026 Annual Meeting. The board recommends voting FOR all four proposals: electing two Class III directors (Hollings Renton and John P. Schmid), ratifying KPMG LLP as auditor, approving say-on-pay, and amending the 2017 Equity Incentive Plan. This is a routine management proxy solicitation with no contested matters or activist involvement.
Key Financial Metrics
Key Facts
- Annual Meeting scheduled for August 11, 2026 at 9:00 AM Pacific Time
- Record date for stockholders is June 22, 2026
- Board recommends FOR votes on all four proposals
- Proposals include election of two Class III directors, auditor ratification, say-on-pay vote, and equity plan amendment
- Director nominees: Hollings Renton and John P. Schmid
- KPMG LLP proposed as independent auditor for fiscal year ending June 30, 2027
- This is definitive additional materials (DEFA14A), not the definitive proxy statement itself
Financial Impact
No financial figures disclosed in this filing. The equity plan amendment may involve share reserve increases but no amounts are stated.
Risk Factors
- Equity plan amendment could be dilutive if share reserve increase is large
- Say-on-pay vote may receive low support if compensation practices are controversial, though no opposition has been filed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-288431 |
| Document: 0001193125-26-288431-index-headers.html | 0001193125-26-288431 |
| Document: 0001193125-26-288431-index.html | 0001193125-26-288431 |
| Document: 0001193125-26-288431.txt | 0001193125-26-288431 |
Track record
28 reports on ANAB
10 of 19 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 13 of 19 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
- Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
- Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
- Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
- Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
- Jun 29, 202620w ago DEFA14A Neutral 2/10 Viewing Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
- Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
- Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
- Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers